Literature DB >> 8384701

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

M Kopf1, G Le Gros, M Bachmann, M C Lamers, H Bluethmann, G Köhler.   

Abstract

Murine T-helper clones are classified into two distinct subsets (Th1 and Th2) on the basis of their patterns of lymphokine secretion. Th1 clones secrete interleukin-2 (IL-2), tumour necrosis factor-beta (TNF-beta) and interferon-gamma (IFN-gamma), whereas Th2 clones secrete IL-4, IL-5 and IL-10 (ref. 1). These subsets are reciprocally regulated by IL-4, IL-10 and IFN-gamma and differentially promote antibody or delayed-type hypersensitivity responses. To evaluate whether IL-4 is required for mounting Th2 responses, we generated IL-4-mutant mice (IL-4-/-) and assessed the cytokine secretion pattern of T cells both from naive and Nippostrongylus brasiliensis infected mice. CD4+ T cells from naive IL-4-/- mice failed to produce Th2-derived cytokines after in vitro stimulation. The levels of Th2 cytokines IL-5, IL-9 and IL-10 from CD4+ T cells obtained after nematode infection were significantly reduced. The reduced IL-5 production in IL-4-/- mice correlated with reduced helminth-induced eosinophilia, which has been shown to be dependent on IL-5 in vivo. We conclude that IL-4 is required for the generation of the Th2-derived cytokines and that immune responses dependent on these cytokines are impaired.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384701     DOI: 10.1038/362245a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  282 in total

1.  CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice.

Authors:  Y Ikehara; Y Yasunami; S Kodama; T Maki; M Nakano; T Nakayama; M Taniguchi; S Ikeda
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice.

Authors:  T Zhang; Y Maekawa; J Hanba; T Dainichi; B F Nashed; H Hisaeda; T Sakai; T Asao; K Himeno; R A Good; N Katunuma
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

Review 3.  Th1/Th2 balance in atopy.

Authors:  T Biedermann; M Röcken
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

5.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.

Authors:  K I Seino; K Fukao; K Muramoto; K Yanagisawa; Y Takada; S Kakuta; Y Iwakura; L Van Kaer; K Takeda; T Nakayama; M Taniguchi; H Bashuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 6.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 7.  JAK-STAT signaling in asthma.

Authors:  Alessandra B Pernis; Paul B Rothman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

8.  Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.

Authors:  Sho Shibata; Kensuke Miyake; Tomoya Tateishi; Soichiro Yoshikawa; Yoshinori Yamanishi; Yasunari Miyazaki; Naohiko Inase; Hajime Karasuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

9.  Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors.

Authors:  J Schmidt; S Fleissner; I Heimann-Weitschat; R Lindstaedt; I Szelenyi
Journal:  Agents Actions       Date:  1994-10

10.  Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Authors:  Jennifer Kearley; Karen F Buckland; Sara A Mathie; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.